European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Corwave SA, Clichy, France

Watch
Corwave SA

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Create Dossier
Corwave SA

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Risk report
Corwave SA
Risk Level Evaluation Source
Sanctioned (?)
Anti-trust proceedings (?)

Name

Corwave SA

Identification

Sirul
Siren 538993452
Siret
Siret 53899345200050
Lei
969500IU4QHIOSR15444
EUID
FR9201.538993452

Address

19 de l'Europe, 92110 Clichy, France
Paris, France

Corporate purpose

72.19
Other research and experimental development on natural sciences and engineering

Research, development, production, production, marketing of medical devices

Financial performance

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
1Chair of the board
1Director-General
4Director
1Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Patents
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2017 to 2025
Profit & Loss
from 2017 to 2025
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

2 Jul 2026
Annual report for the year ending 31/12/2025 · Balance sheet for 31/12/2025 · Earnings statement for 31/12/2025
8 Apr 2026
Patent: Implantable blood pump that includes a linear bearing
17 Mar 2026
Chair: Gérard Hascoet · Deputy Managing Director: L. Le DUC de Lillers · Director (6) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit …
8 Aug 2025
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (6) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit · Corporate Purpose
22 Jul 2025
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (6) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit · Corporate Purpose
18 Mar 2025
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (7) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit · Corporate Purpose
11 Mar 2025
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (5) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit · Corporate Purpose
15 Jan 2025
Patent: Systems for controlling an implantable blood pump
6 Nov 2024
Patent: Implantable pump system with a rectangular membrane
30 Jul 2024
DG: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (6) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit · Capital: €9,927,946 …
7 Apr 2024
Capital: €9,485,530 · Corporate Purpose
14 Nov 2023
Patent: Implantable heart pump system with an improved apical plug and/or graft plug
17 Jul 2023
DG: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (7) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: BCRH & Associes, Ernst & Young Audit …
13 Jul 2023
Director: Clothilde Lauzeral
24 Apr 2023
Patent: Blood Pumps Having an Encapsulated Actuator
13 Nov 2022
Capital: €7,814,183 · Corporate Purpose
28 Jul 2022
Capital: €7,322,610 · Corporate Purpose
18 Jul 2022
Address
17 Apr 2022
Capital: €6,831,037 · Corporate Purpose
4 Jan 2022
DG: L. le Duc de Lillers · Director (5) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Bcrh & Associes Sàrl, Ernst & Young Audit SAS à capital variable
15 Aug 2021
Capital: €5,356,023 · Corporate Purpose
9 Jul 2021
Director-General: L. le Duc de Lillers · Director: L. le Duc de Lillers
30 Jun 2021
Director-General: L. le Duc de Lillers · Director: L. le Duc de Lillers
26 May 2021
Patent: Implantable Pump System Having an Undulating Membrane
26 May 2021
Patent: Implantable Pump System Having a Coaxial Ventricular Cannula
7 Apr 2021
Director-General: L. le Duc de Lillers · Director: L. le Duc de Lillers
12 Feb 2021
Capital: €5,257,708 · Corporate Purpose
11 Feb 2021
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (5) · Director: Ysios Capital Partners S.G.E.I.C. · Auditor: BCRH & Associes, Ernst & Young Audit · Corporate Purpose
14 Jul 2020 in Hor
EU funding (€2,495,675): The next-generation heart pump to change patients’ lives and create a new standard of care
5 Jun 2020
Wordmark: “FIDELITY“
28 Apr 2020
DG: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (7) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: BCRH & Associes, Ernst & Young Audit …
26 Nov 2019
Patent: Apparatus and Methods for Coupling a Blood Pump to the Heart
23 Oct 2019
Wordmark: “NEPTUNE“
28 Jul 2019
Chair of the board: Gérard Hascoet · Dep.DG: L. Le DUC de Lillers · Director (5) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: BCRH & Associes, Ernst & Young Audit
25 Jul 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
27 Dec 2018
Director-General: L. le Duc de Lillers · Director: L. le Duc de Lillers
26 Dec 2018
Director: L. le Duc de Lillers
22 Nov 2018
Patent: Implantable pump system with a corrugated membrane with improved hydraulic performance
9 Nov 2018
Patent: Liquid circulator with wavy membrane
2 Aug 2018
Wordmark: “NEMO“
11 Jul 2018
Director-General: L. Le DUC de Lillers · Chair of the board: Gérard Hascoet · Director (6) · Director: Bpifrance Investissement, Ysios Capital Partners S. G. E. I. C. · Auditor (3 companies)
22 Jun 2018
Capital: €3,048,983
6 May 2018
Director-General: L. Le DUC de Lillers · Chair: Gérard Hascoet · Director (5) · Director: Bpifrance Investissement, Ysios Capital Partners S. G. E. I. C. · Auditor: Beas, Deloitte & Associés
3 May 2018
Director: Ysios Capital Partners S.G.E.I.C
17 Nov 2017
Director: E. Coutanceau
17 Nov 2017
No longer Director: AMS R&D SAS · Capital: €2,223,854
16 Nov 2017
Capital: €2,223,854
7 Nov 2017
No longer Director: AMS R&d SAS
17 Oct 2017
Address
1 Sept 2017 in Hor
EU funding: Reduced Order Modelling, Simulation and Optimization of Coupled systems
30 Apr 2017
Director (2) · Director: Ysios Capital Partners S.G.E.I.C. · No longer Director: Sofinnova Partners · Capital: €2,223,854
24 Apr 2017
DG: L. le Duc de Lillers · Chair: Gérard Hascoet · Director (3) · Director: AMS R&D SAS, Bpifrance Investissement SAS, Ysios Capital Partners S.G.E.I.C. SA · Auditor: Beas Sàrl, Deloitte & Associés SA
11 Apr 2017
Patent: Implantable Pump System Having an Undulating Membrane
9 Jun 2016
Chair of the board: Gérard Hascoet · Capital: €986,221
23 Mar 2016
Director-General (1) · President (1) · Director (1) · Capital: €986,221
16 Oct 2015
Director-General (1) · No longer Director: MD Strat I GmbH & Co.KG · Capital: €986,221
10 Jul 2014
Capital: €986,221 · Corporate Purpose
9 May 2014
Chair of the board: Gérard Hascoet · No longer President: Gérard Hascoet · Director (4) · Director (4 companies) · Capital: €986,221
16 Apr 2014
Address
31 Dec 2013
Legal form: SA à conseil d'administration (s.a.i.)
31 Dec 2013 as Corwave SAS
Capital: €1,250,333
26 Dec 2013 as Corwave SAS
Auditor: Beas, Deloitte & Associés · Capital: €1,250,333
17 Jul 2013 as Corwave SAS
Capital: €1,250,333
11 Jun 2013 as Corwave SAS
Address
27 Sept 2012 as Corwave SAS
No longer Director (1) · Capital: €1,110,333
13 Sept 2012 as Corwave SAS
Director: AMS R&D SAS · Capital: €1,110,333
31 Jan 2012 as Corwave SAS
Capital: €650,000 · Corporate Purpose
1 Dec 2011 as Corwave SAS
Address · Legal form: SAS, société par actions simplifiée · Name: CORWAVE · Segment clas­si­fi­ca­tion
There are no publications matching your search.

Mentions

23 Jul 2026 in Rne
Reg­is­tra­tion: 18/07/2022 · DG: L. le Duc de Lillers · Chair: Gerard Hascoet · Director (4) · Director: Bpifrance Investissement, Ysios Capital Partners S.G.E.I.C. · Auditor: Ernst & Young Audit SAS
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.